Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

CMR May Improve Assessment of ICD Need in Cardiac Sarcoidosis

Todd Neale

June 11, 2025

News Daily News

PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a)

Michael O'Riordan

June 10, 2025

News Daily News

Conversion Therapy Tied to Worse CV Risk Factors in Sexual, Gender Minorities

Caitlin E. Cox

May 08, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Daily News

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

Yael L. Maxwell

May 05, 2025

News Daily News

Black Adults Face CV Mortality Beyond Their Predicted Risk

Caitlin E. Cox

April 18, 2025

News Daily News

AHA Tackles Need for Increased CV Prevention in Emerging Adults

Yael L. Maxwell

April 09, 2025

News Daily News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Michael O'Riordan

March 13, 2025

News Daily News

Years After Radiation Therapy, Echo Parameters Worse in Breast Cancer Patients

Caitlin E. Cox

March 11, 2025

News Daily News

High Survival Rates Seen in Sports-Related Cardiac Arrest in Canada

Michael O'Riordan

February 10, 2025

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

News Daily News

Early Actions by Trump Administration Sow Uncertainty for CV Research

Todd Neale

January 30, 2025

News Daily News

AHA Stats Show CV Health of Americans Remains Dire

Michael O'Riordan

January 28, 2025

News Daily News

Aspirin Use for Primary Prevention Declining in US: NHANES

Michael O'Riordan

January 24, 2025

News Daily News

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

L.A. McKeown

January 10, 2025

Advertisement

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

CMR May Improve Assessment of ICD Need in Cardiac Sarcoidosis

PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a)

Conversion Therapy Tied to Worse CV Risk Factors in Sexual, Gender Minorities

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

Black Adults Face CV Mortality Beyond Their Predicted Risk

AHA Tackles Need for Increased CV Prevention in Emerging Adults

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Years After Radiation Therapy, Echo Parameters Worse in Breast Cancer Patients

High Survival Rates Seen in Sports-Related Cardiac Arrest in Canada

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Early Actions by Trump Administration Sow Uncertainty for CV Research

AHA Stats Show CV Health of Americans Remains Dire

Aspirin Use for Primary Prevention Declining in US: NHANES

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content